TIMP2*IGFBP7 is one of very few AKI biomarkers that are commercially available in laboratory assays sold under the tradename NEPHROCHECK© (Astute Medical Inc., San Diego, CA, USA) with increasing usage, especially in ICU departments [103,104]. This evidence concerns the gene IGFBP7 and acute kidney injury.